Key result
Phosphorothioate oligodeoxynucleotides inhibit influenza A and C replication, reducing viral plaques by ~6 logs.
Why the study?
The antiviral activity of phosphorothioate oligodeoxynucleotides against influenza A and C viruses was investigated due to lack of effective inhibition by unmodified oligomers.
Phosphorothioate oligodeoxynucleotides demonstrate antiviral activity against influenza A and C viruses in vitro, whereas unmodified phosphodiester oligomers do not.
Supports preclinical antiviral development of S-ODNs; leaves open translation to in vivo efficacy or clinical use.
Oligodeoxynucleotides (ODNs) were synthesized and tested for their antiviral activity against influenza viruses. ODNs corresponded to the polymerase PB1 gene of either influenza A/WSN/33 virus or influenza C/JJ/50 virus. All compounds were 20 nucleotides long, including control ODNs containing mismatches. The phosphodiester ODNs (O-ODNs) failed to inhibit replication of influenza A and influenza C viruses at concentrations up to 80 microM, possibly due to intracellular nuclease digestion of the unmodified oligomers. By contrast, the phosphorothioate derivatives (S-ODNs) were found to inhibit replication of both influenza A and influenza C virus. The antiviral effect of S-ODNs against influenza A virus was found at concentrations as low as 1.25 microM and was present with mismatched oligomers. In the case of influenza C virus, the S-ODN complementary to the 3' end of the viral RNA of the PB1 gene revealed a sequence-specific antiviral activity at a concentration of 20 microM. (At the same concentration, S-ODNs with one or three mismatches showed little or no antiviral activity.) Reduction in plaque number reached six logarithms when this sequence-specific S-ODN was used at a concentration of 80 microM.
No takes yet. Share an insight, caveat, or question.
Leiter et al. (1990) studied Influenza A and C virus infection (in vitro). Phosphorothioate oligodeoxynucleotides (S-ODNs) vs. Phosphodiester ODNs (O-ODNs) and mismatched ODNs was evaluated on Inhibition of influenza virus replication. Phosphorothioate oligodeoxynucleotides inhibited replication of influenza A and C viruses, with sequence-specific S-ODNs reducing plaque number by six logarithms at 80 microM against influenza C.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: